These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 30295338)

  • 1. Fingolimod enhances the efficacy of delayed alteplase administration in acute ischemic stroke by promoting anterograde reperfusion and retrograde collateral flow.
    Tian DC; Shi K; Zhu Z; Yao J; Yang X; Su L; Zhang S; Zhang M; Gonzales RJ; Liu Q; Huang D; Waters MF; Sheth KN; Ducruet AF; Fu Y; Lou M; Shi FD
    Ann Neurol; 2018 Nov; 84(5):717-728. PubMed ID: 30295338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of the Immune Modulator Fingolimod With Alteplase in Acute Ischemic Stroke: A Pilot Trial.
    Zhu Z; Fu Y; Tian D; Sun N; Han W; Chang G; Dong Y; Xu X; Liu Q; Huang D; Shi FD
    Circulation; 2015 Sep; 132(12):1104-1112. PubMed ID: 26202811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale and design of combination of an immune modulator Fingolimod with Alteplase bridging with Mechanical Thrombectomy in Acute Ischemic Stroke (FAMTAIS) trial.
    Zhang S; Zhou Y; Zhang R; Zhang M; Campbell B; Lin L; Shi FD; Lou M
    Int J Stroke; 2017 Oct; 12(8):906-909. PubMed ID: 28569122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endovascular therapy for ischemic stroke with perfusion-imaging selection.
    Campbell BC; Mitchell PJ; Kleinig TJ; Dewey HM; Churilov L; Yassi N; Yan B; Dowling RJ; Parsons MW; Oxley TJ; Wu TY; Brooks M; Simpson MA; Miteff F; Levi CR; Krause M; Harrington TJ; Faulder KC; Steinfort BS; Priglinger M; Ang T; Scroop R; Barber PA; McGuinness B; Wijeratne T; Phan TG; Chong W; Chandra RV; Bladin CF; Badve M; Rice H; de Villiers L; Ma H; Desmond PM; Donnan GA; Davis SM;
    N Engl J Med; 2015 Mar; 372(11):1009-18. PubMed ID: 25671797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of fingolimod combined with alteplase in acute ischemic stroke and rehabilitation nursing.
    Liantao Z; Jing Z; Lingling L; Hua L
    Pak J Pharm Sci; 2019 Jan; 32(1(Special)):413-419. PubMed ID: 30852478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of tenecteplase versus alteplase for acute ischemic stroke.
    Parsons M; Spratt N; Bivard A; Campbell B; Chung K; Miteff F; O'Brien B; Bladin C; McElduff P; Allen C; Bateman G; Donnan G; Davis S; Levi C
    N Engl J Med; 2012 Mar; 366(12):1099-107. PubMed ID: 22435369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute ischemic stroke: imaging-guided tenecteplase treatment in an extended time window.
    Parsons MW; Miteff F; Bateman GA; Spratt N; Loiselle A; Attia J; Levi CR
    Neurology; 2009 Mar; 72(10):915-21. PubMed ID: 19273826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-immunogenic recombinant staphylokinase versus alteplase for patients with acute ischaemic stroke 4·5 h after symptom onset in Russia (FRIDA): a randomised, open label, multicentre, parallel-group, non-inferiority trial.
    Gusev EI; Martynov MY; Nikonov AA; Shamalov NA; Semenov MP; Gerasimets EA; Yarovaya EB; Semenov AM; Archakov AI; Markin SS;
    Lancet Neurol; 2021 Sep; 20(9):721-728. PubMed ID: 34418399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Clinical, Imaging, and Thrombus Characteristics With Recanalization of Visible Intracranial Occlusion in Patients With Acute Ischemic Stroke.
    Menon BK; Al-Ajlan FS; Najm M; Puig J; Castellanos M; Dowlatshahi D; Calleja A; Sohn SI; Ahn SH; Poppe A; Mikulik R; Asdaghi N; Field TS; Jin A; Asil T; Boulanger JM; Smith EE; Coutts SB; Barber PA; Bal S; Subramanian S; Mishra S; Trivedi A; Dey S; Eesa M; Sajobi T; Goyal M; Hill MD; Demchuk AM;
    JAMA; 2018 Sep; 320(10):1017-1026. PubMed ID: 30208455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombus Migration and Fragmentation After Intravenous Alteplase Treatment: The INTERRSeCT Study.
    Ohara T; Menon BK; Al-Ajlan FS; Horn M; Najm M; Al-Sultan A; Puig J; Dowlatshahi D; Calleja Sanz AI; Sohn SI; Ahn SH; Poppe AY; Mikulik R; Asdaghi N; Field TS; Jin A; Asil T; Boulanger JM; Letteri F; Dey S; Evans JW; Goyal M; Hill MD; Almekhlafi M; Demchuk AM;
    Stroke; 2021 Jan; 52(1):203-212. PubMed ID: 33317416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of Collaterals is Associated with Larger Infarct Volume and Worse Outcome in Patients with Large Vessel Occlusion and Mild Symptoms.
    Kimmel ER; Al Kasab S; Harvey JB; Bathla G; Ortega-Gutierrez S; Toth G; Jaksich EM; Sheharyar A; Roa J; Hasan DM; Samaniego EA
    J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1987-1992. PubMed ID: 31036341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Computed Tomography Perfusion Imaging on the Response to Tenecteplase in Ischemic Stroke: Analysis of 2 Randomized Controlled Trials.
    Bivard A; Huang X; McElduff P; Levi CR; Campbell BC; Cheripelli BK; Kalladka D; Moreton FC; Ford I; Bladin CF; Davis SM; Donnan GA; Muir KW; Parsons MW
    Circulation; 2017 Jan; 135(5):440-448. PubMed ID: 27965285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Reperfusion After Thrombolysis With Clinical Outcome Across the 4.5- to 9-Hours and Wake-up Stroke Time Window: A Meta-Analysis of the EXTEND and EPITHET Randomized Clinical Trials.
    Campbell BCV; Ma H; Parsons MW; Churilov L; Yassi N; Kleinig TJ; Hsu CY; Dewey HM; Butcher KS; Yan B; Desmond PM; Wijeratne T; Curtze S; Barber PA; De Silva DA; Thijs V; Levi CR; Bladin CF; Sharma G; Bivard A; Donnan GA; Davis SM
    JAMA Neurol; 2021 Feb; 78(2):236-240. PubMed ID: 33137171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized assessment of rapid endovascular treatment of ischemic stroke.
    Goyal M; Demchuk AM; Menon BK; Eesa M; Rempel JL; Thornton J; Roy D; Jovin TG; Willinsky RA; Sapkota BL; Dowlatshahi D; Frei DF; Kamal NR; Montanera WJ; Poppe AY; Ryckborst KJ; Silver FL; Shuaib A; Tampieri D; Williams D; Bang OY; Baxter BW; Burns PA; Choe H; Heo JH; Holmstedt CA; Jankowitz B; Kelly M; Linares G; Mandzia JL; Shankar J; Sohn SI; Swartz RH; Barber PA; Coutts SB; Smith EE; Morrish WF; Weill A; Subramaniam S; Mitha AP; Wong JH; Lowerison MW; Sajobi TT; Hill MD;
    N Engl J Med; 2015 Mar; 372(11):1019-30. PubMed ID: 25671798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relevance of Collaterals for the Success of Neuroprotective Therapies in Acute Ischemic Stroke: Insights from the Randomized URICO-ICTUS Trial.
    Amaro S; Renú A; Laredo C; Castellanos M; Arenillas JF; Llull L; Rudilloso S; Urra X; Obach V; Chamorro Á;
    Cerebrovasc Dis; 2019; 47(3-4):171-177. PubMed ID: 31163434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke.
    Campbell BCV; Mitchell PJ; Churilov L; Yassi N; Kleinig TJ; Dowling RJ; Yan B; Bush SJ; Dewey HM; Thijs V; Scroop R; Simpson M; Brooks M; Asadi H; Wu TY; Shah DG; Wijeratne T; Ang T; Miteff F; Levi CR; Rodrigues E; Zhao H; Salvaris P; Garcia-Esperon C; Bailey P; Rice H; de Villiers L; Brown H; Redmond K; Leggett D; Fink JN; Collecutt W; Wong AA; Muller C; Coulthard A; Mitchell K; Clouston J; Mahady K; Field D; Ma H; Phan TG; Chong W; Chandra RV; Slater LA; Krause M; Harrington TJ; Faulder KC; Steinfort BS; Bladin CF; Sharma G; Desmond PM; Parsons MW; Donnan GA; Davis SM;
    N Engl J Med; 2018 Apr; 378(17):1573-1582. PubMed ID: 29694815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial.
    Davis SM; Donnan GA; Parsons MW; Levi C; Butcher KS; Peeters A; Barber PA; Bladin C; De Silva DA; Byrnes G; Chalk JB; Fink JN; Kimber TE; Schultz D; Hand PJ; Frayne J; Hankey G; Muir K; Gerraty R; Tress BM; Desmond PM;
    Lancet Neurol; 2008 Apr; 7(4):299-309. PubMed ID: 18296121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protocol for the perfusion and angiography imaging sub-study of the Third International Stroke Trial (IST-3) of alteplase treatment within six-hours of acute ischemic stroke.
    Wardlaw JM; von Kummer R; Carpenter T; Parsons M; Lindley RI; Cohen G; Murray V; Kobayashi A; Peeters A; Chappell F; Sandercock PA
    Int J Stroke; 2015 Aug; 10(6):956-68. PubMed ID: 23336348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tenecteplase in ischemic stroke offers improved recanalization: Analysis of 2 trials.
    Bivard A; Huang X; Levi CR; Spratt N; Campbell BCV; Cheripelli BK; Kalladka D; Moreton FC; Ford I; Bladin CF; Davis SM; Donnan GA; Muir KW; Parsons MW
    Neurology; 2017 Jul; 89(1):62-67. PubMed ID: 28576782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.